Robert Paul Brigance

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 6 EPO patents. Top assignees: Bristol-Myers Squibb Compnay, American Cyanamid Company, Idemitsu Kosan Company, Limited. Active years: 1999-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Paul Brigance. Retrieved from https://idiyas.com/inventor/robert-paul-brigance

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 51(Granted Patents)

Location History:

Levitttown, PA (US) (2018)
Levittown, PA (US) (1999 - 2021)

Company Filing History:

12 out of 3,737

Bristol-Myers Squibb Compnay

patents

3 out of 3,580

American Cyanamid Company

patents

1 out of 2,283

Idemitsu Kosan Company, Limited

patents

4. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2021

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10966967 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2021-04-06),

2. 10695328 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2020-06-30),

3. 10669261 - Heteroarylhydroxypyrimidinones as agonists of the APJ receptor (2020-06-02),

4. 10590113 - 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists (2020-03-17),

5. 10369140 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2019-08-06),

6. 10106528 - 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists (2018-10-23),

7. 9901572 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2018-02-27),

8. 9663466 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2017-05-30),

9. 9187424 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2015-11-17),

10. 8791091 - Aryl dihydropyridinone and piperidinone MGAT2 inhibitors (2014-07-29),

11. 7635699 - Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods (2009-12-22),

12. 7589088 - Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods (2009-09-15),

13. 6294676 - Process for the preparation of 6-(arylcarbonyl)-4-oximo-dihydrobenzothiopyran herbicides and intermediates useful therein (2001-09-25),

14. 6087498 - Process for the preparation of unsymmetrical 4,6-bis(aryloxy) pyrimidine (2000-07-11),

15. 6008402 - Process for the preparation of (1999-12-28),

Title: The Innovative Journey of Robert Paul Brigance

Introduction: Robert Paul Brigance, a talented inventor hailing from Levittown, PA, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Robert Paul Brigance's latest patents include a cutting-edge smart home device that revolutionizes the way we interact with our living spaces, and a sustainable energy solution aimed at reducing carbon emissions.

Career Highlights: With a career spanning over two decades, Robert Paul Brigance has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has been recognized with numerous awards and accolades in the industry.

Collaborations: Throughout his career, Robert Paul Brigance has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful development and commercialization of several groundbreaking technologies.

Conclusion: In conclusion, Robert Paul Brigance's passion for innovation and his relentless drive to push the boundaries of what is possible have cemented his status as a pioneering inventor in the field of technology. His contributions continue to inspire the next generation of inventors to think outside the box and create a better future for all.

Profile summary based on public USPTO records.